S17-231 Nanoparticle platform to activate self-specific CD8+ T cells to improve antitumor immune response Researchers at Stanford have developed a nanoparticle-based platform to enhance activation of self-specific CD8+ T cells in the tumor microenvironment to fight cancer while minimizing toxic side effects. Qian Yin Yu Wong Mark Davis